However, there is also a great deal of evidence showed that the expression of SIRT1 in breast cancer, ovarian carcinoma, bladder carcinoma, prostate carcinoma, and glioblastoma, is lower than that in normal tissues [18]. The gene discussed is SIRT1; the disease is prostate carcinoma.